Phasebio Pharmaceuticals Inc
(PHAS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | MTVA | GRI | ||
| Company | Phasebio Pharmaceuticals Inc | Metavia Inc | Gri Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0800 | 1.8300 | 2.25 | ||
| High | 0.0920 | 1.9600 | 2.36 | ||
| Low | 0.0665 | 1.5400 | 2.23 | ||
| Latest | 0.0701 | 1.6400 | 2.31 | ||
| Change | -0.0249 | -0.0200 | +0.06 | ||
| % Change | -26.21% | -1.20% | +2.67% | ||
| Volume | 9,647,400 | 2,400,500 | 33,300 | ||
| 20-Day Average Volume | 3,930,150 | 423,980 | 970,845 | ||
| Previous Close | 0.0950 | 1.6600 | 2.25 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 2.2610 | 3.81 | ||
| 20-Day Raw Stochastic | 2.27% | 5.38% | 4.24% | ||
| 20-Day Relative Strength | 20.88 | 28.09 | 24.99 | ||
| Weighted Alpha | -91.26 | -79.59 | -82.92 | ||
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 72% Sell | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | -9.89% since 02/06/26 | -3.35% since 02/06/26 | ||
| Low | 0.0665 on 11/02/22 | 1.5400 on 02/13/26 | 2.10 on 02/12/26 | ||
| High | 0.1440 on 10/27/22 | 1.9600 on 02/13/26 | 2.53 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | -78.84% since 01/13/26 | -61.66% since 01/13/26 | ||
| Low | 0.0665 on 11/02/22 | 1.5400 on 02/13/26 | 2.10 on 02/12/26 | ||
| High | 0.2250 on 10/14/22 | 7.5100 on 01/14/26 | 7.56 on 01/14/26 | ||
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | -77.41% since 11/13/25 | -95.12% since 11/13/25 | ||
| Low | 0.0665 on 11/02/22 | 1.5400 on 02/13/26 | 2.10 on 02/12/26 | ||
| High | 1.3800 on 08/09/22 | 13.4200 on 12/08/25 | 64.12 on 11/24/25 | ||
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | -76.70% since 08/13/25 | -93.65% since 08/13/25 | ||
| Low | 0.0665 on 11/02/22 | 1.5400 on 02/13/26 | 2.10 on 02/12/26 | ||
| High | 1.3800 on 08/09/22 | 19.0289 on 09/15/25 | 80.36 on 09/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 3,610 | 3,338 | ||
| Shares Outstanding, K | 49,858 | 2,201 | 1,445 | ||
| Annual Sales | 10,830,000 | 0 | 0 | ||
| Annual Net Income | -131,070,000 | -27,590,000 | -11,960,000 | ||
| Last Quarter Sales | 210,000 | 0 | 0 | ||
| Last Quarter Net Income | -16,670,000 | -3,380,000 | -2,660,000 | ||
| 60-Month Beta | 2.57 | 0.27 | -1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | -1.54 on 11/06/25 | -1.28 on 11/14/25 | ||
| Latest Earnings Date | 11/09/22 | 03/19/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 12/19/19 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||